Modern Diagnostic & Research Centre reported a revenue increase to ₹8,311.06 lakh for FY 2026, though PAT dropped to ₹525.33 lakh. The company, which recently completed its IPO and moved to a public listing, is prioritizing network expansion over dividends to fuel growth in Haryana and Uttar Pradesh.
Modern Diagnostic Reports FY26 Revenue Growth Amid Margin Pressure
Operating revenue reached ₹8,311.06 lakh, while Profit After Tax (PAT) declined to ₹525.33 lakh.
Reader Takeaway: Revenue growth signals strong demand, but high expansion costs have compressed margins and halted dividend payouts.
What just happened
Modern Diagnostic & Research Centre Ltd (MDRC) released its annual performance update for FY 2025-26. The company saw top-line growth, with revenue increasing from ₹7,794.54 lakh in the previous fiscal year. However, bottom-line profitability saw a significant contraction, with PAT falling from ₹900.79 lakh to ₹525.33 lakh. The EBITDA margin narrowed to 16.18%, down from 24.00% in the prior year.
Why this matters
This transition year for MDRC marks its shift from a private to a public entity following its January 2026 IPO. The drop in profitability reflects the heavy investment phase the company is currently navigating. By choosing not to pay a dividend, management is signaling that internal capital preservation is the current priority to fund the rollout of new diagnostic centers and infrastructure upgrades.
Network and Operational Expansion
The company has expanded its laboratory footprint to 25 centers, with a roadmap to hit 30. Significant capital has been deployed toward upgrading facilities, including the relocation of the Sector 44 center to Sector 40 to accommodate advanced imaging technology like PET-CT and SPECT. Infrastructure work in Aligarh and Lucknow is also underway as part of the strategy to reduce reliance on the Haryana market, which currently accounts for over half of total revenue.
Strategic Outlook
Management is betting on digital transformation to recover margins, specifically through in-house CRM and AI-driven workflow dashboards. The core focus is on stabilizing operations in new territories across Uttar Pradesh.
Risks to watch
Profitability compression remains the primary concern for retail investors. While scaling is necessary for long-term dominance, the company faces execution risk in proving that new centers can deliver the necessary return on investment (ROI) to restore margins to historical levels.
What to track next
Watch for the operational performance of the new labs in Lucknow and Aligarh in the coming quarters. Investors should monitor whether the management’s digital initiatives succeed in optimizing operational costs and improving the turnaround time for test results.